Home › Funds › TORONTO DOMINION BANK › STOK
TORONTO DOMINION BANK position in STOK
STOKE THERAPEUTICS INC · Health Care
TORONTO DOMINION BANK reported holding 3,173,258 shares of STOK (STOKE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$103.8M, representing 0.34% of its reported portfolio and ranking #47 among its reported holdings. TORONTO DOMINION BANK has disclosed STOK holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How TORONTO DOMINION BANK's STOK position evolved
TORONTO DOMINION BANK first disclosed a stake in STOK in Q4 2024 at 3,173,258 shares (US$35.0M). The position peaked in Q2 2026 at 3,173,258 shares, worth US$103.8M. Across 7 filings, TORONTO DOMINION BANK held the position steady without any share-count change. The most recent filing (Q2 2026) shows 3,173,258 shares valued at US$103.8M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 3.17M | $35.00M | New |
| Q1 2025 | 3.17M | $21.10M | Hold |
| Q2 2025 | 3.17M | $36.02M | Hold |
| Q3 2025 | 3.17M | $74.57M | Hold |
| Q4 2025 | 3.17M | $100.72M | Hold |
| Q1 2026 | 3.17M | $103.32M | Hold |
| Q2 2026 | 3.17M | $103.83M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About STOK and 13F data
STOK (STOKE THERAPEUTICS INC) is a Health Care company. 52 other funds we track also report a position in STOK — the largest reported positions include RTW INVESTMENTS, LP (US$184.0M), Lynx1 Capital Management LP (US$132.1M), Redmile Group, LLC (US$129.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding STOK
- RTW INVESTMENTS, LP 5.62M sh · $184.00M · Q2 2026
- Lynx1 Capital Management LP 4.04M sh · $132.14M · Q2 2026
- Redmile Group, LLC 3.95M sh · $129.11M · Q2 2026
- BAKER BROS. ADVISORS LP 3.34M sh · $109.18M · Q2 2026
- BVF INC/IL 2.55M sh · $83.36M · Q2 2026
- Siren, L.L.C. 2.00M sh · $65.29M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.82M sh · $59.66M · Q2 2026
- EcoR1 Capital, LLC 735.00K sh · $24.05M · Q2 2026
- MPM BioImpact LLC 723.31K sh · $23.67M · Q2 2026
- Opaleye Management Inc. 700.00K sh · $22.90M · Q2 2026
- Troluce Capital Advisors LLC 496.42K sh · $16.24M · Q2 2026
- Granahan Investment Management, LLC 461.61K sh · $15.10M · Q2 2026
More on TORONTO DOMINION BANK
FAQ
How long has TORONTO DOMINION BANK held STOK?
TORONTO DOMINION BANK has disclosed STOK holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is TORONTO DOMINION BANK's current position in STOK?
As of Q2 2026, TORONTO DOMINION BANK holds 3.17M shares of STOK (STOKE THERAPEUTICS INC), valued at $103.83M, representing 0.34% of its reported portfolio and ranking #47.
Has TORONTO DOMINION BANK been buying or selling STOK?
In the latest 13F filing (Q2 2026), TORONTO DOMINION BANK held unchanged its position in STOK. The position peaked in Q2 2026 at 3.17M shares.
Which other funds hold STOK?
Other major institutional holders of STOK include RTW INVESTMENTS, LP, Lynx1 Capital Management LP, Redmile Group, LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.